Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.771660
Title: Improving the outcomes for high-risk neuroblastoma through the optimisation of radiotherapeutic techniques
Author: Gains, J. E.
ISNI:       0000 0004 7659 3332
Awarding Body: UCL (University College London)
Current Institution: University College London (University of London)
Date of Award: 2015
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
Neuroblastoma is a childhood cancer with highly variable clinical behaviour and outcomes. The long-term survival rate for high-risk neuroblastoma remains poor and new therapeutic advances and optimisation of existing therapies is therefore required. Both external beam radiotherapy and molecular radiotherapy have a significant role to play in the multi-modality treatment of high-risk disease. This collection of work examines ways in which the outcome for neuroblastoma may be improved through the introduction of new and enhancement of existing radiotherapeutic techniques. 131I-meta-Iodobenzylguanidine molecular radiotherapy has been used in the treatment of neuroblastoma since the mid 1980's. Despite this, its role and efficacy remain undefined. A systematic review of 131I-mIBG therapy in neuroblastoma is therefore presented. Radiolabelled somatostatin analogues target a distinct and separate molecular target on neuroblastoma cells to the noradrenaline transporter targeted by 131I-mIBG. This study reports on the use of radiolabelled somatostatin analogues for the imaging and therapy of patients with high-risk neuroblastoma. The expression of the two different molecular targets by immunohistochemistry for the noradrenaline transporter molecule and somatostatin receptor type-2 in archived neuroblastoma tumour samples is also explored. The radiation doses received by comforters and carers providing necessary support to children undergoing molecular radiotherapy over a 10 year period is presented. The gold standard imaging modality for response assessment in neuroblastoma is 123I-mIBG scinitgraphy. The role of other functional imaging techniques such as 18F- FDG PET/CT remains undefined. This study will look to see if 18F-FDG PET/CT can give additional information with regards to response assessment. External beam radiotherapy is standardly delivered using conventional anterior and posterior parallel opposed beams and this can result in a compromise on target volume coverage to stay within the tolerance of normal tissues. The use of an Intensity Modulated Arc Therapy technique to improve target volume coverage is examined.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.771660  DOI: Not available
Share: